KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea
· Delayed Price · Currency is KRW 14,880
-170 (-1.13%)
Last updated: Mar 25, 2025
KOREA PHARMA Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 3,792 | 83.76 | -1,119 | 6,368 | 3,159 | Upgrade
|
| Depreciation & Amortization | 2,797 | 2,813 | 2,380 | 2,377 | 2,221 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.14 | -0.32 | -81.9 | -5.29 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 279.24 | 606.42 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -364.1 | -1,910 | 42.2 | -1.93 | -0.9 | Upgrade
|
| Loss (Gain) on Equity Investments | -1,644 | 1,724 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 164.84 | Upgrade
|
| Provision & Write-off of Bad Debts | -187.6 | 214.09 | 103.16 | -157.11 | -143.36 | Upgrade
|
| Other Operating Activities | 7,797 | 4,856 | 8,436 | 1,440 | 2,172 | Upgrade
|
| Change in Accounts Receivable | -701.76 | 1,111 | 1,322 | -1,140 | -333.61 | Upgrade
|
| Change in Inventory | -1,436 | -1,254 | -381.27 | 2,613 | -7,448 | Upgrade
|
| Change in Accounts Payable | 99.42 | 189.93 | 376.94 | -1,969 | 803.72 | Upgrade
|
| Change in Other Net Operating Assets | -2,383 | -3,613 | -2,798 | -2,333 | -1,468 | Upgrade
|
| Operating Cash Flow | 8,046 | 4,819 | 8,279 | 7,192 | -873.84 | Upgrade
|
| Operating Cash Flow Growth | 66.95% | -41.79% | 15.11% | - | - | Upgrade
|
| Capital Expenditures | -3,249 | -1,531 | -2,465 | -2,552 | -1,974 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.07 | - | 215.41 | 5.3 | 46.77 | Upgrade
|
| Sale (Purchase) of Intangibles | -552.2 | -1,146 | -287.14 | -897.72 | -670.4 | Upgrade
|
| Investment in Securities | -8,535 | 47,476 | -49,239 | -8,464 | -2,114 | Upgrade
|
| Other Investing Activities | 0 | -0 | - | - | -0 | Upgrade
|
| Investing Cash Flow | -12,335 | 44,899 | -51,875 | -12,908 | -4,711 | Upgrade
|
| Short-Term Debt Issued | 4,000 | 4,000 | - | - | 7,771 | Upgrade
|
| Long-Term Debt Issued | - | 23,000 | - | 49,997 | - | Upgrade
|
| Total Debt Issued | 4,000 | 27,000 | - | 49,997 | 7,771 | Upgrade
|
| Short-Term Debt Repaid | -5,160 | -4,000 | -3,000 | -3,000 | -8,000 | Upgrade
|
| Long-Term Debt Repaid | -13,591 | -39,112 | -1,018 | -1,089 | -3,932 | Upgrade
|
| Total Debt Repaid | -18,751 | -43,112 | -4,018 | -4,089 | -11,932 | Upgrade
|
| Net Debt Issued (Repaid) | -14,751 | -16,112 | -4,018 | 45,908 | -4,161 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 16,606 | Upgrade
|
| Dividends Paid | -545.34 | -545.34 | -545.34 | -545.34 | -439.27 | Upgrade
|
| Other Financing Activities | - | -3.43 | - | - | -0 | Upgrade
|
| Financing Cash Flow | -15,296 | -16,661 | -4,563 | 45,363 | 12,005 | Upgrade
|
| Foreign Exchange Rate Adjustments | 69.72 | -23.44 | 9.36 | 28.69 | 0.87 | Upgrade
|
| Net Cash Flow | -19,516 | 33,034 | -48,150 | 39,675 | 6,421 | Upgrade
|
| Free Cash Flow | 4,797 | 3,288 | 5,815 | 4,640 | -2,848 | Upgrade
|
| Free Cash Flow Growth | 45.87% | -43.45% | 25.31% | - | - | Upgrade
|
| Free Cash Flow Margin | 5.90% | 3.95% | 7.18% | 5.83% | -3.98% | Upgrade
|
| Free Cash Flow Per Share | 440.24 | 314.06 | 478.44 | 421.87 | -292.05 | Upgrade
|
| Cash Interest Paid | 268.17 | 312.67 | 219.12 | 159.93 | 390.78 | Upgrade
|
| Cash Income Tax Paid | 202.81 | 2,297 | 348.39 | -354.44 | 1,012 | Upgrade
|
| Levered Free Cash Flow | 2,638 | -1,693 | 1,395 | 1,004 | -4,674 | Upgrade
|
| Unlevered Free Cash Flow | 4,439 | 642.87 | 3,812 | 1,571 | -4,402 | Upgrade
|
| Change in Net Working Capital | -1,639 | 3,144 | -317.27 | 489.77 | 7,020 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.